Treeline Biosciences, Inc., a biotechnology company based in Watertown, MA, has successfully completed a fundraising round, raising $200.1 million as reported in their SEC Form D filing dated September 4, 2025. The total offering amount was set at $250 million, indicating strong investor interest.
Related articles
Press ReleaseSeptember 16, 2026
ASSA ABLOY
ASSA ABLOY acquires PACLOCK in the US
September 16, 2026
Press ReleaseSeptember 16, 2026
MySize
MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv
Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform
September 16, 2026
← Back to all articles
Generated by Olivia 6